Supplementary Materials and Methods Fig. S1 to S9 Tables S1 to S5 References for SI reference citations 1808696 Crystal Structure Determination Data were indexed, integrated and scaled using XDS (4). The structure was solved by molecular replacement using a modified version of the HuR RRM1 structure (PDB code 3HI9) in PHASER (5). The structure was refined using PHENIX (6). COOT (7) was used for manual inspection and model building. RNA was built in manually. In the final model, all residues were in the favored regions (99%) of the Ramachandran plot with 0.3% outliers, generated by PHENIX. The value of 0.3% for outliers is due to the same amino acid in all four chains being outside the preferred or allowed region.
Supplementary Materials and Methods
Cloning and site-directed mutagenesis The sequence containing the C-terminal RRM domain (residue 241-326, RRM3) was amplified by PCR from the pTXB1-HuR plasmid (1) introducing NcoI and EcoRI restriction sites and subcloned into the pETGB-1a vector (EMBL, kind gift from Drs Arie Geerlof and Gunter Stier). To generate mammalian expression constructs, full-length HuR was sub cloned between the XhoI and HindIII cleavage sites into pcDNA3.1+ (Invitrogen) with an inserted Flag-tag between NheI and HindIII. Mutations were introduced into pETGB-1a-HuR, pETGB-1a-RRM3, pcDNA3.1+Flag-HuR according to the QuickChange Site-Directed Mutagenesis protocol from Stratagene. The first two RRM domains of HuR in a modified Novagen pET28a vector were described before (2) . Generation of the dual luciferase reporter psiCHECK-2 containing 60 nt of the murine COX-2 3'UTR was described previously (3) . The COX-2 AtoU mutant, where all adenines are mutated to uracils, was synthesized by General Biosystems, Inc.
Expression and Purification of recombinant proteins
Recombinant human 6-his-tagged -GB1-fusion proteins (RRM3, RRM3 W261E, RRM3 FY) were over expressed in BL21(DE3) cells (Novagen). Cells were grown in LB rich or M9 minimal media supplemented with 15 NH4Cl or 15 NH4Cl and 13 C-glucose at 37°C until OD600 reached 0.6-0.8, temperature was reduced to 20°C and the expression induced with 0.5 mM isopropyl β-D-thiogalactoside (IPTG). Cells were harvested by centrifugation at 4°C, 20 min at 6000rpm after 19-22 h. Cell pellet was either stored at -20°C or lysed with a microfluidizer at 75 PSI (0.52 MPa) in 20 mM Tris-HCl (pH8), 800 mM NaCl, 2 mM MgSO4, 5 mM CaCl2, 10 mM imidazole, 10 mM β-mercaptoethanol, 0.25 mg/mL lysozyme, 10 µg/mL DNase, one complete EDTA free protease inhibitor tablet (Roche) in a total volume of 50 ml. Lysate was cleared by centrifugation at 4°C, 40 min and 17000 rpm and was applied onto a 5 ml HiTrap Chelating HP column (GE Healthcare) charged with nickel and purified on a AKTA prime system (washed with 20 mM Tris-HCl pH8, 800 mM NaCl, 10 mM imidazole and 10 mM β-mercaptoethanol and eluted with 50% same buffer but 500 mM imidazole. Pooled fractions were dialysed against 3 L buffer (20 mM Na2HPO4 (pH7), 100 mM NaCl, 1 mM EDTA, 1 mM DTT and without imidazole) in the presence of an in house made TEV protease (1:50 ratio mg-TEV: mg-RRM3) at room temperature overnight to remove the 6-his-GB1-tag. Additional dialysis against 2 L of same buffer but no EDTA was performed for 4h. The protein was further purified by reloading the sample on the HiTrap Chelating HP column to remove the 6-his-GB1-tag, overnight dialysis as above, followed by size exclusion chromatography using the Superdex75 prep grade size exclusion column (GE Healthcare) in 20 mM Na2HPO4 (pH7), 100 mM NaCl, 1 mM DTT. The protein was stored in size exclusion/NMR buffer at -80°C.
While the RNA electron density clearly indicates uridines bound in pockets 2 and 3 in all four chains, the electron density for the nucleotide in chain E and G in pocket 1 (β2-β3 loop) and 4 (β3) is not well defined. Therefore, it was unclear whether to build an adenine or uridine at this position.
Refinements were performed of all possible combinations: adenine or uridine in pocket 1 or 4 (in chain E and G), including anti and syn conformations. For all, the difference density map showed always a negative density in pocket 1 and 4, which we explained by the occupancy of both adenines and uridines in these pockets. Therefore, the occupancy factor in the pdb file was manually set to 0.5 for the nucleotides in pocket 1 and 4, including the side chain Q253 in pocket 1 before the last rounds of refinement with PHENIX. In the final structure, the A1 base in chain E adopted occupancy values from 0.56-0.74, depending on the atom, while the other three nucleotides (U4 in chain E, U1 and A4 in chain G respectively, adopted occupancy value 1. All structures with multiple combinations show only little differences in R-values. For the final structure, based on the slightly better R values and quality of the electron density, shown as 2Fo−Fc density contoured at a sigma level of 1. 
NMR spectroscopy
All NMR spectroscopy measurements were done in 20 mM Na2HPO4 (pH7), 100 mM NaCl, 1 mM DTT, 10% D2O at 298K using Buker AVIII-500 MHz, AVIII-600 MHz and AVIII-700 MHz (equipped with cryoprobes) and AVIII-750 MHz. For the 1 H, 15 N and 13 C assignments of the protein backbone of RRM12 2D 1 H, 15 N-HSQC and 3D HNCO, HN(CA)CO, HNCA, HN(CO)CA, HNCACB, CBCA(CO)NH and 3D 15 N-NOESY-HSQC (mixing time of 100 ms) spectra were recorded. 2D 1 H, 15 N-HSQC and 3D HNCA, HNCACB, CBCA(CO)NH and 3D 15 N-NOESY-HSQC (mixing time of 100 ms) were recorded for RRM3 and 2D 1 H, 15 N-HSQC, 3D HNCA, HNCACB for W261E. For RNA titrations, various RNA sequences were titrated into 15 N labelled RRM3 at about 100 μM. The combined chemical shift difference was calculated according to (δH 2 +(δN/6.51) 2 ) 1/2 , were δH and δN were the difference in the 1 H and 15 N chemical shifts respectively. 2D 1 H-1 H-TOCSY experiments (mixing time of 50 ms in H2O and 60 ms in D2O) of protein RNA complexes were recorded to observe the H5-H6 cross-peaks. 2D NOESY was measured of a 1:1 15 N RRM3: AUUAUU in D2O (mixing time of 150 ms) to determine the syn or anti conformation of the adenine in pocket 1. NMR data were processed with Topspin 3.1 (Bruker) and the analysis performed using Sparky (T. D. Goddard and D. G. Kneller, SPARKY 3, University of California San Francisco) T1 and T2 relaxation experiments were carried out on the AVIII-750 MHz at 298 K at various concentrations of 15 N-labelled or 13 C-15 N-labelled RRM3, 0.3 mM 15 N -labelled W261 and 0.4 mM 15 Nlabelled RRM12. Longitudinal relaxation time T1 were determined from a pseudo-3D experiment with twelve delay times ranging from 12-3000 ms (Bruker Pulse sequence hsqct1etf3gpsi3d.2). Transverse relaxation times T2 were obtained from 1 H-15 N correlation spectra with ten different delay times (17-271 ms) (Bruker Pulse sequence hsqct2etf3gpsi3d). 15 N T1, 15 N T2 and the corresponding standard deviation (SD) for each residue were determined by fitting the peak heights from each spectrum to a decaying exponential using Sparky (rh command) (8) . Correlation times (τc) for each residue were calculated from the T1 / T2 ratio (9, 10) . Molecular weights were roughly estimated by τc/0.6, assuming a spherical particle at 298K (10) .
Camcoil was used for Cα random coil chemical shifts calculations (11) .
Isothermal titration calorimetry.
Protein and RNA/DNA oligonucleotides were dialyzed or dissolved respectively in 20 mM Na2HPO4 (pH7), 100 mM NaCl and 10 mM β-mercaptoethanol. To estimate the affinities for various DNA and RNA motifs, DNA/RNA was titrated into protein solution by 35 injections of 8 μl every 300s (at 307 rpm). At least two replicates were measured. To estimate the dimerization constant, 8 μl of 35 sequential injections were used with the concentrated protein diluted into buffer.
Molecular Dynamics Simulations
The simulated systems included HuR RRM3 complexed with 5'-UUUA-3' (chain C/G), 5'-AUUUU-3' (chain A/E), 5'-UUUUU-3' (obtained by superimposing chains A/E and C/G), or 5'-UAUUUAU-3' (obtained by superimposing chains A/E and C/G and by addition of one nucleotide at each of their termini). The underlined nucleotides are those located in binding pockets 1 and 4. The length of the simulations was 1 μs and two parallel simulations of each system were conducted. A single simulation of the 5'-UAUUUAU-3' system was extended up to 3 μs to more thoroughly explore the syn conformation of the adenine located in pocket 1. We have used ff12SB (12) and χOL3 (13) force fields to describe protein and RNA, respectively. The simulations were performed in explicit-solvent conditions using the standard equilibration and simulation protocol for protein/RNA complexes (14) . The HBfix potential function (15) was applied in all simulations to improve structural stability of the protein/RNA interface. The minimization and equilibration of the individual simulated HuR protein/RNA complexes was done by the sander module of AMBER 16. The fully solvated initial structures were first relaxed using a series of alternating minimization and equilibration runs with a gradually diminishing positional restraint potential applied to all solute atoms. Specifically, the initial topology and coordinates were prepared in tLeap where the complex was solvated in octahedral box of SPC/E waters (16) with a minimal distance of 13 Å between the solute and the box border. The KCl ions (17) were used to neutralize the system with overall excess-salt concentration of 0.15 M.
The built systems were then subjected to a minimization run using 1000 steps and a solute positional restraint of 25 kcal/mol/Å 2 . Note that first half (first 500 steps) of all minimizations was computed using the steepest descent method while the second half (last 500 steps) was computed as conjugated gradients. The initial minimization run was followed by 100 ps-long simulation in an NVT (constant volume) ensemble in which we gradually heated the system from 100 K to 300 K while applying the same positional restraint to all solute atoms as in the initial minimization. We have used Berendsen weak-coupling thermostat (18) with a default coupling constant of 1 ps to regulate the system's temperature. This calculation was followed with another 1000 minimization steps, followed by a 50 ps-long NPT (constant pressure) simulation with solute positional restraint set to 5 kcal/mol/Å 2 in both calculations. The Berendsen weak-coupling barostat was used to regulate the pressure in the NPT equilibration runs using the coupling value of 0.2 ps. Afterwards, we have repeated the cycles of 1000 minimization steps followed by 50 pslong NPT simulation with a gradually lowering positional restraint of 4, 3, 2, 1, and 0.5 kcal/mol/Å 2 , respectively.
The production simulations were performed using the pmemd.cuda module of AMBER 16. We have used the particle mesh Ewald method and periodic boundary conditions to calculate the electrostatic interactions in all calculations. The cut-off distance of the non-bonded Lennard-Jones interactions was 9 Å. The SHAKE algorithm (19) along with hydrogen mass repartitioning (20) was used in all simulations, allowing a 4 fs-long integration step. The temperature and pressure in the production NPT simulations was maintained at 300 K and l bar using the Berendsen weak-coupling thermostat with a coupling value of 1 ps and the Monte-Carlo barostat, respectively. In all production simulations of the HuR RRM3 protein/RNA complex, a stabilizing HBfix potential of 1 kcal/mol was applied in the 3-4 Å donor-acceptor range to the U2(O4)/Q316(NE2), U2(N3)/Q316(OE1), and U3(O2)/T321(N) H-bonds. The U2 and U3 indicate uracils bound in binding pockets 2 and 3, respectively. Due to their large dynamics, the HBfix was not applied for the nucleotides in binding pockets 1 and 4. HBfix is a gentle short-range structure-specific tuning of the force field designed as a compensation for polarization effects that contribute to H-bonding but are neglected by the force field. A more detailed description of this approach can be found in (21, 22) .
Cell culture, luciferase assay, qPCR and western blot In Huh7 cells, 1 μl: 1 μg Lipofectamine: DNA ratio was used for transfections. For luciferase assays, 0.1 μg psiCHECK-2 -COX2-1-60 was co-transfected with 1 μg pcDNA or pcDNA-HuR/HuR mutants per well in a 24 well plate, each well seeded with 0.5*10 5 cells the night before. For qPCR, 2 μg plasmid DNA was transfected in a 6 well plate, each well seeded with 1*105 cells the night before. Cells were harvested after 48h and total RNA was extracted using the Macherey-Nagel NucleoSpin® RNA Kit. cDNA was generated by reverse transcription (M-MLV Reverse Transcriptase, RNase H Minus (Promega) of 1 μg of RNA using the Oligo (dT) 15 Primer (Promega). Quantitative PCR was performed using the iTaq™ Universal SYBR ® Green Supermix (Bio-Rad) as described in the manufacturer's instructions and supplemented with genespecific primers (listed below). RPLP0 house keeping gene was used as a normalization control. Fold changes in mRNA expression were normalized according to the ΔΔCt method.
Protein concentration of the cell lysates was determined using BCA assay. For western blots analysis, after 12% SDS-PAGE, proteins were transferred to a PVDF transfer membrane. The membrane was blocked in TBST-5% milk blotting powder for 1 h at RT. Afterwards, the membrane was incubated with mouse Monoclonal ANTI-FLAG M2 antibody (Sigma #F3165, 1:2500 in TBST-5% milk blotting powder) or mouse Monoclonal Anti-α-Tubulin antibody (Sigma #041M4798, 1:20000 in TBST-5% milk blotting powder) overnight at 4°C. After secondary antibody incubation with Anti-Mouse IgG (whole molecule)-Peroxidase antibody (Sigma #A9044, in 1:50000 in TBST-5% milk blotting powder) for 1h at RT, western was detected by using the Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare). C3H/10T1/2 cells, multipotent cells isolated from C3H mouse embryo cells, were cultured in DMEM with L-glutamine (Corning), 10% FBS, 1% penicillin/ streptomycin (Life Technologies), 1 mM sodium pyruvate (Thermo Scientific) at 37°C and 5% CO2. On day one, 12-well plates were seeded with 2*10 4 cells/ml. On the next day, 25 nM of scrambled-RNA (control) or si-HuR RNA (5'-AUGUGAAAGUGAUUCGUGAtt-3', manufactured by Ambion Life Technologies) was transfected using TransIT-siQUEST (Mirus), as described by the manufacturer's instructions. After 36 h, cells were transfected with 0.1 μg psiCHECK-2 -COX2-1-60 and 0.5 μg pcDNA or pcDNA-HuR/HuR mutants using the TransIT-LT1 (Mirus). For the luciferase assay, cells were harvested after 24h and collected in RNase free conditions, washed with sterile PBS and resuspended in 50ml Passive Lysis buffer per million cells. Renilla luciferase signal was generated and recorded by employing Dual Luciferase® Reported Assay System (Promega) and SpectraMax® L Luminometer (Molecular Devices) according to manufacturer instructions. Renilla signal was normalized to the firefly signal. 4-hydroxytamoxifen was purchased from Millipore, the stock was diluted at 500 mM in ethanol and used at 1 µM in DMEM. Tamoxifen treatment was done for 72 hours before the cells were harvested for qPCR analysis. RNA was extracted using the RNeasy Mini Kit (Invitrogen, CAT# 74104) according to the manufacturer's instructions. DNase treatment was systematically performed. Quantification of extracted RNA were assessed using Nanodrop. The cDNA was synthesized using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, CAT# 4368814). mRNA was analyzed by real-time PCR using iTaq Universal SYBR Green Supermix (Bio Rad, CAT# 172-5124). GAPDH house keeping gene was used as a normalization control. Fold changes in mRNA expression were normalized according to the ΔΔCt method.
For western blots, cells were lysed in RIPA lysis buffer (1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 50 mM Tris, pH 7.4, 2 mM Na3VO4, 25 mM β-glycerophosphate, 15 mM NaF, and complete protease inhibitor mix; Roche) and lysate cleared by centrifugation at 13,000 rpm for 10 min at 4˚C. Lysate protein concentration was determined for each sample using BCA assay. Equal amounts of lysate resolved by 10% SDS-PAGE and transferred to a PVDF transfer membrane. Membrane was blocked in 5% BSA in TBS-T at 4˚C. Primary antibodies were incubated at 4˚C overnight. Secondary ECL antibodies (GE Healthcare) were incubated for 1h at RT in 5% Milk in TBS-T. Protein was imaged using chemiluminescence method and Genemate autoradiography film. The following antibody dilutions were used: rabbit anti-ELAVL1 (Cell Signaling #12582, 1:1000), rabbit anti-β-tubulin (Cell Signaling #2146, 1:1000), rabbit anti-Flag (Cell Signaling #2368, 1:1000).
Primers for qPCR (Huh7 cells)
Primers used in Huh7 cells were derived from the PrimerBank (23). 15 N HSQC spectra of free RRM3 (blue) overlaid with 6 equivalents (eq.) EDTA (red), 12 eq. MgCl2 (yellow), 6 eq. ATP (green), 12 eq. MgCl2 (cyan), and 12 eq. ATP (magenta). (D) 1 H-15 N HSQC spectra of free RRM3 (blue) overlaid with 1:1.5 RRM3:cfos (cyan) and 1:9 RRM3:polyA (magenta). Negative peaks corresponding to the amides of arginine side chains in the free and the RNA bound form in green. Examples of different exchange regimes are indicated by a box and shown in a closeup view on the right. 
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